US Patent 7744881 Human DR4 antibodies and uses thereof

Patent 7744881 was granted and assigned to Genentech on June, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7744881

Date of Patent

June 29, 2010

Patent Application Number

11819575

Date Filed

June 28, 2007

Patent Citations Received

‌

US Patent 11891446 Highly potent antibodies binding to death receptor 5

Patent Primary Examiner

‌

Lorraine Spector

Patent abstract

Human Death Receptor 4 (DR4) antibodies are provided. The human DR4 antibodies may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treatment and diagnosis using the DR4 antibodies are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7744881 Human DR4 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API